title: Chronic kidney disease: How effective and safe are antiplatelet agents in CKD?
authors: Division of Nephrology and Immunology, Rheinisch-Westfälische Technische Hochschule Aachen, Pauwelsstrasse 30, 52074 Aachen, Germany. juergen.floege@rwth-aachen.de
authors: Jürgen
authors: J
authors: Floege
authors: Georg
authors: G
authors: Schlieper
mesh_terms: D006801:Humans; D009203:Myocardial Infarction / Q000517:prevention & control*; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use*; D051436:Renal Insufficiency, Chronic / Q000150:complications*; D020521:Stroke / Q000517:prevention & control*
chemical_list: D010975:Platelet Aggregation Inhibitors
references: N Engl J Med. 2005 Jul 21;353(3):238-48
references: 16034009
references: Nat Rev Cardiol. 2013 May;10(5):261-73
references: 23419899
references: Ann Intern Med. 2002 Oct 1;137(7):563-70
references: 12353943
references: Chest. 2010 Nov;138(5):1093-100
references: 20299623
references: Clin J Am Soc Nephrol. 2009 Aug;4(8):1347-55
references: 19578002
references: Am J Kidney Dis. 2013 Jan;61(1):112-22
references: 23022428
references: Cochrane Database Syst Rev. 2013 Feb 28;(2):CD008834
references: 23450589
references: Kidney Int. 2009 Jul;76(1):18-22
references: 19387474